A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
<p><strong>Introduction: </strong>Developing and evaluating novel compounds for treatment or prophylaxis of emerging infectious diseases is costly and time-consuming. Repurposing of already available marketed compounds is an appealing option as they already have an establi...
| Main Authors: | , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado: |
Taylor and Francis
2022
|